Retension Pharmaceuticals files for Nasdaq IPO at $12 per share
Retension Pharmaceuticals filed a final prospectus for its initial public offering. Its common stock is set to trade on the Nasdaq Capital Market under ticker RTSN at $12.00 per share.
Retension Pharmaceuticals filed a final prospectus for its initial public offering. Its common stock is set to trade on the Nasdaq Capital Market under ticker RTSN at $12.00 per share.